Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.
about
Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysisMaternal polycystic ovary syndrome and the risk of autism spectrum disorders in the offspring: a population-based nationwide study in SwedenAspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome.Serum testosterone predicts cardiorespiratory fitness impairment in normal-weight women with polycystic ovary syndrome.
P2860
Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.
@en
Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.
@nl
type
label
Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.
@en
Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.
@nl
prefLabel
Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.
@en
Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.
@nl
P2093
P2860
P1433
P1476
Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome.
@en
P2093
Athanasios Karachalios
Christos Pappas
Dimitrios Panidis
Evangelos Marinakis
Maria Drakou
Nikoleta Tolia
Philippos Kaldrymides
Sarantis Livadas
P2860
P2888
P304
P356
10.1007/S12020-014-0200-7
P577
2014-04-22T00:00:00Z